Cargando…
Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs
Glioblastoma multiforme (GBM) is the most malignant primary brain tumor and has the highest mortality rate among cancers and high resistance to radiation and cytotoxic chemotherapy. Although some targeted therapies can partially inhibit oncogenic mutation-driven proliferation of GBM cells, therapies...
Autores principales: | Zhang, Jing, Jing, Li, Tan, Subee, Zeng, Er-Ming, Lin, Yingbo, He, Lingfeng, Hu, Zhigang, Liu, Jianping, Guo, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393494/ https://www.ncbi.nlm.nih.gov/pubmed/32732911 http://dx.doi.org/10.1038/s41419-020-02812-3 |
Ejemplares similares
-
VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
por: Shields, Julie A., et al.
Publicado: (2022) -
miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012) -
Circ_0061140 stimulates the malignant development of prostate cancer by targeting miR-1193
por: Wang, Kai, et al.
Publicado: (2021) -
Glioblastoma Multiforme in a Patient With Alpha-1-Antitrypsin Deficiency
por: Ober, Curtis, et al.
Publicado: (2023)